Dipeptidyl Peptidase 4 Inhibitors
Molecular Models
Virtual Work
Accelerators
Eukaryotic Transcription Inhibitors
Dynamic Equilibrium
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 10, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Nathaly Vasquez-Martínez1, Jonathan Trapala2, Laura I Álvarez-Añorve1
1Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, México.
Novel computational methods identified new dipeptidyl peptidase 4 (DPP-4) inhibitors for type 2 diabetes. Compounds EPZ005687, OSU-03012, and bemcentinib show high efficacy and improved cellular absorption compared to existing drugs.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: